New Drugs FDA Approves Symdeko (tezacaftor/ivacaftor and ivacaftor) to Treat Cystic Fibrosis in People Ages 12 and Older with Certain Mutations in the CFTR Gene 7 years ago
Pharma Industry News FDA tells Celltrion a consultant may be in order for its troubled biologics plant 7 years ago
Healthcare News Molina’s costly company overhaul, missing CSR payments lead to fourth-quarter loss 7 years ago
Pharma Industry News The Association for Accessible Medicines announces 2018 Board of Directors 7 years ago